29.58 USD
-0.57 (-1.89%)
29.58 USD
0 (0%)
We assign a fundamental rating of 4 out of 10 to FLGT. FLGT was compared to 101 industry peers in the Health Care Providers & Services industry. While FLGT seems to be doing ok healthwise, there are quite some concerns on its profitability. FLGT is valied quite expensively at the moment, while it does show a decent growth rate.
1. Profitability
1.1 Basic Checks
FLGT had positive earnings in the past year.
FLGT had a positive operating cash flow in the past year.
In multiple years FLGT reported negative net income over the last 5 years.
FLGT had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
Looking at the Return On Assets, with a value of -3.54%, FLGT is doing worse than 64.36% of the companies in the same industry.
Looking at the Return On Equity, with a value of -3.82%, FLGT is in line with its industry, outperforming 49.51% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -3.54% | ||
| ROE | -3.82% | ||
| ROIC | N/A |
ROA(3y)-2.25%
ROA(5y)12.71%
ROE(3y)-2.41%
ROE(5y)14.84%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
With a decent Gross Margin value of 41.24%, FLGT is doing good in the industry, outperforming 69.31% of the companies in the same industry.
FLGT's Gross Margin has declined in the last couple of years.
FLGT does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 41.24% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-21.53%
GM growth 5Y-7.75%
2. Health
2.1 Basic Checks
FLGT does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, FLGT has more shares outstanding
Compared to 5 years ago, FLGT has more shares outstanding
The debt/assets ratio for FLGT has been reduced compared to a year ago.
2.2 Solvency
An Altman-Z score of 7.38 indicates that FLGT is not in any danger for bankruptcy at the moment.
The Altman-Z score of FLGT (7.38) is better than 91.09% of its industry peers.
A Debt/Equity ratio of 0.00 indicates that FLGT is not too dependend on debt financing.
FLGT has a Debt to Equity ratio of 0.00. This is amongst the best in the industry. FLGT outperforms 86.14% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 7.38 |
ROIC/WACCN/A
WACC8.84%
2.3 Liquidity
FLGT has a Current Ratio of 7.01. This indicates that FLGT is financially healthy and has no problem in meeting its short term obligations.
FLGT has a better Current ratio (7.01) than 97.03% of its industry peers.
FLGT has a Quick Ratio of 7.01. This indicates that FLGT is financially healthy and has no problem in meeting its short term obligations.
Looking at the Quick ratio, with a value of 7.01, FLGT belongs to the top of the industry, outperforming 97.03% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 7.01 | ||
| Quick Ratio | 7.01 |
3. Growth
3.1 Past
FLGT shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -60.27%.
The Earnings Per Share has been growing by 22.18% on average over the past years. This is a very strong growth
The Revenue has grown by 13.60% in the past year. This is quite good.
Measured over the past years, FLGT shows a very strong growth in Revenue. The Revenue has been growing by 54.21% on average per year.
EPS 1Y (TTM)-60.27%
EPS 3Y-68.94%
EPS 5Y22.18%
EPS Q2Q%-54.84%
Revenue 1Y (TTM)13.6%
Revenue growth 3Y-34.15%
Revenue growth 5Y54.21%
Sales Q2Q%17.18%
3.2 Future
FLGT is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -41.72% yearly.
Based on estimates for the next years, FLGT will show a quite strong growth in Revenue. The Revenue will grow by 11.14% on average per year.
EPS Next Y-172.16%
EPS Next 2Y-83.49%
EPS Next 3Y-41.72%
EPS Next 5YN/A
Revenue Next Year12.97%
Revenue Next 2Y11.77%
Revenue Next 3Y11.14%
Revenue Next 5YN/A
3.3 Evolution
The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
4. Valuation
4.1 Price/Earnings Ratio
FLGT is valuated quite expensively with a Price/Earnings ratio of 102.00.
FLGT's Price/Earnings ratio is in line with the industry average.
Compared to an average S&P500 Price/Earnings ratio of 26.31, FLGT is valued quite expensively.
FLGT is expected to report negative earnings next year, which makes the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 102 | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
A cheap valuation may be justified as FLGT's earnings are expected to decrease with -41.72% in the coming years.
PEG (NY)N/A
PEG (5Y)4.6
EPS Next 2Y-83.49%
EPS Next 3Y-41.72%
5. Dividend
5.1 Amount
No dividends for FLGT!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
29.58
-0.57 (-1.89%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners53.98%
Inst Owner Change5.82%
Ins Owners33.16%
Ins Owner Change-1.16%
Market Cap914.32M
Revenue(TTM)315.55M
Net Income(TTM)-42.98M
Analysts80
Price Target34.34 (16.09%)
Short Float %9.16%
Short Ratio6.8
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)149.45%
Min EPS beat(2)137.43%
Max EPS beat(2)161.46%
EPS beat(4)4
Avg EPS beat(4)137.97%
Min EPS beat(4)121.2%
Max EPS beat(4)161.46%
EPS beat(8)8
Avg EPS beat(8)161.48%
EPS beat(12)11
Avg EPS beat(12)118.12%
EPS beat(16)15
Avg EPS beat(16)122.7%
Revenue beat(2)2
Avg Revenue beat(2)3.23%
Min Revenue beat(2)1.21%
Max Revenue beat(2)5.24%
Revenue beat(4)3
Avg Revenue beat(4)1.43%
Min Revenue beat(4)-1.8%
Max Revenue beat(4)5.24%
Revenue beat(8)5
Avg Revenue beat(8)0.7%
Revenue beat(12)9
Avg Revenue beat(12)5.2%
Revenue beat(16)13
Avg Revenue beat(16)7.57%
PT rev (1m)32.9%
PT rev (3m)32.9%
EPS NQ rev (1m)113.43%
EPS NQ rev (3m)113.43%
EPS NY rev (1m)0%
EPS NY rev (3m)22.39%
Revenue NQ rev (1m)2.36%
Revenue NQ rev (3m)2.36%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 102 | ||
| Fwd PE | N/A | ||
| P/S | 2.87 | ||
| P/FCF | N/A | ||
| P/OCF | 594.51 | ||
| P/B | 0.8 | ||
| P/tB | 0.94 | ||
| EV/EBITDA | N/A |
EPS(TTM)0.29
EY0.98%
EPS(NY)-0.67
Fwd EYN/A
FCF(TTM)-0.65
FCFYN/A
OCF(TTM)0.05
OCFY0.17%
SpS10.31
BVpS36.78
TBVpS31.54
PEG (NY)N/A
PEG (5Y)4.6
Graham Number15.49
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -3.54% | ||
| ROE | -3.82% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 41.24% | ||
| FCFM | N/A |
ROA(3y)-2.25%
ROA(5y)12.71%
ROE(3y)-2.41%
ROE(5y)14.84%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-21.53%
GM growth 5Y-7.75%
F-Score7
Asset Turnover0.26
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 88.3% | ||
| Cap/Sales | 6.77% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 7.01 | ||
| Quick Ratio | 7.01 | ||
| Altman-Z | 7.38 |
F-Score7
WACC8.84%
ROIC/WACCN/A
Cap/Depr(3y)101.39%
Cap/Depr(5y)338.11%
Cap/Sales(3y)8.31%
Cap/Sales(5y)7.13%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-60.27%
EPS 3Y-68.94%
EPS 5Y22.18%
EPS Q2Q%-54.84%
EPS Next Y-172.16%
EPS Next 2Y-83.49%
EPS Next 3Y-41.72%
EPS Next 5YN/A
Revenue 1Y (TTM)13.6%
Revenue growth 3Y-34.15%
Revenue growth 5Y54.21%
Sales Q2Q%17.18%
Revenue Next Year12.97%
Revenue Next 2Y11.77%
Revenue Next 3Y11.14%
Revenue Next 5YN/A
EBIT growth 1Y19.94%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year47.88%
EBIT Next 3Y23.19%
EBIT Next 5YN/A
FCF growth 1Y-192.32%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-96.64%
OCF growth 3Y-66.06%
OCF growth 5Y30.8%
FULGENT GENETICS INC / FLGT FAQ
Can you provide the ChartMill fundamental rating for FULGENT GENETICS INC?
ChartMill assigns a fundamental rating of 4 / 10 to FLGT.
What is the valuation status for FLGT stock?
ChartMill assigns a valuation rating of 0 / 10 to FULGENT GENETICS INC (FLGT). This can be considered as Overvalued.
What is the profitability of FLGT stock?
FULGENT GENETICS INC (FLGT) has a profitability rating of 2 / 10.
What is the valuation of FULGENT GENETICS INC based on its PE and PB ratios?
The Price/Earnings (PE) ratio for FULGENT GENETICS INC (FLGT) is 102 and the Price/Book (PB) ratio is 0.8.
What is the expected EPS growth for FULGENT GENETICS INC (FLGT) stock?
The Earnings per Share (EPS) of FULGENT GENETICS INC (FLGT) is expected to decline by -172.16% in the next year.